Article in Antioxidants (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 11 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors at 2 institutions in 1 country.
Ana TodorovićDepartment of Molecular Biology and Endocrinology, VINČA Institute of Nuclear Sciences-National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-2074-1637
Katarina BobićDepartment of Molecular Biology and Endocrinology, VINČA Institute of Nuclear Sciences-National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0001-9575-0960
Filip VeljkovićDepartment of Physical Chemistry, VINČA Institute of Nuclear Sciences-National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-4471-334X
Snežana PejićDepartment of Molecular Biology and Endocrinology, VINČA Institute of Nuclear Sciences-National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0003-4573-2371
Sofija GlumacInstitute of Pathology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-2720-4148
Sanja StankovićCentre for Medical Biochemistry, University Clinical Centre of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0003-0890-535X
Tijana MilovanovićPublic Company "Nuclear Facilities of Serbia", 11000 Belgrade, Serbia.
Ivana VukojeDepartment of Radiation Chemistry and Physics, VINČA Institute of Nuclear Sciences-National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0001-9364-2616
Jovan M NedeljkovićDepartment of Radiation Chemistry and Physics, VINČA Institute of Nuclear Sciences-National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.
Sanja Radojević ŠkodrićInstitute of Pathology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Snežana B PajovićDepartment of Molecular Biology and Endocrinology, VINČA Institute of Nuclear Sciences-National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.
Dunja DrakulićDepartment of Molecular Biology and Endocrinology, VINČA Institute of Nuclear Sciences-National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0003-1448-9639
University of Belgrade · RSUniversity of Kragujevac · RS
Funding
Ministry of Science, Technological Development and Innovation of the Republic of Serbia 451‒03‒47/2023‒01/200017 and 200110Science Fund of the Republic of Serbia Program PRISMA, Grant No. 5354 - HYDIS.
6 · The paper itself
Abstract
Nanoparticles (NPs), a distinct class of particles ranging in size from 1 to 100 nm, are one of the most promising technologies of the 21st century, and titanium dioxide NPs (TiO
Indexed as
chemical modificationshormonal statusnanoparticlesoxidative stressratsreproductive organsTiO2toxicity
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Comparable Toxicity of Surface-Modified TiO · full record | Socratic